News
British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...
Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...
Such medications are just one part of a necessary, holistic approach that includes diet, exercise, and addressing significant ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
Across Wall Street, 44 publicly traded companies were upgraded Tuesday to an equivalent rating of "buy" or "neutral." ...
A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...
Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...
The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results